131 related articles for article (PubMed ID: 35182941)
1. ACTL6A deficiency induces apoptosis through impairing DNA replication and inhibiting the ATR-Chk1 signaling in glioblastoma cells.
Hu X; Pei D; Ci M; Zhang G; Li B; Wang J; Shen Y; Zhai X; Liang P; Cui H
Biochem Biophys Res Commun; 2022 Apr; 599():148-155. PubMed ID: 35182941
[TBL] [Abstract][Full Text] [Related]
2. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
[TBL] [Abstract][Full Text] [Related]
3. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
Xiao Y; Lin FT; Lin WC
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33408251
[TBL] [Abstract][Full Text] [Related]
4. Increased ACTL6A occupancy within mSWI/SNF chromatin remodelers drives human squamous cell carcinoma.
Chang CY; Shipony Z; Lin SG; Kuo A; Xiong X; Loh KM; Greenleaf WJ; Crabtree GR
Mol Cell; 2021 Dec; 81(24):4964-4978.e8. PubMed ID: 34687603
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
Liu K; Graves JD; Lin FT; Lin WC
J Biol Chem; 2021; 296():100382. PubMed ID: 33556369
[TBL] [Abstract][Full Text] [Related]
6. ACTL6A suppresses p21
Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
[TBL] [Abstract][Full Text] [Related]
7. MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.
Xuan F; Huang M; Zhao E; Cui H
Cell Death Dis; 2018 Oct; 9(11):1062. PubMed ID: 30333481
[TBL] [Abstract][Full Text] [Related]
8. The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication.
Edwards TG; Bloom DC; Fisher C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263259
[TBL] [Abstract][Full Text] [Related]
9. ACTL6a enforces the epidermal progenitor state by suppressing SWI/SNF-dependent induction of KLF4.
Bao X; Tang J; Lopez-Pajares V; Tao S; Qu K; Crabtree GR; Khavari PA
Cell Stem Cell; 2013 Feb; 12(2):193-203. PubMed ID: 23395444
[TBL] [Abstract][Full Text] [Related]
10. ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1.
Moiseeva T; Hood B; Schamus S; O'Connor MJ; Conrads TP; Bakkenist CJ
Nat Commun; 2017 Nov; 8(1):1392. PubMed ID: 29123096
[TBL] [Abstract][Full Text] [Related]
11. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.
Myers K; Gagou ME; Zuazua-Villar P; Rodriguez R; Meuth M
PLoS Genet; 2009 Jan; 5(1):e1000324. PubMed ID: 19119425
[TBL] [Abstract][Full Text] [Related]
12. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
Zeng Z; Yang H; Xiao S
BMC Cancer; 2018 Oct; 18(1):1020. PubMed ID: 30348114
[TBL] [Abstract][Full Text] [Related]
13. Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
Karanika S; Karantanos T; Li L; Wang J; Park S; Yang G; Zuo X; Song JH; Maity SN; Manyam GC; Broom B; Aparicio AM; Gallick GE; Troncoso P; Corn PG; Navone N; Zhang W; Li S; Thompson TC
Cell Rep; 2017 Feb; 18(8):1970-1981. PubMed ID: 28228262
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB.
Aasland D; Götzinger L; Hauck L; Berte N; Meyer J; Effenberger M; Schneider S; Reuber EE; Roos WP; Tomicic MT; Kaina B; Christmann M
Cancer Res; 2019 Jan; 79(1):99-113. PubMed ID: 30361254
[TBL] [Abstract][Full Text] [Related]
15. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
J Virol; 2019 May; 93(9):. PubMed ID: 30787154
[TBL] [Abstract][Full Text] [Related]
16. Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer.
Guo Y; Wang J; Benedict B; Yang C; van Gemert F; Ma X; Gao D; Wang H; Zhang S; Lieftink C; Beijersbergen RL; Te Riele H; Qiao X; Gao Q; Sun C; Qin W; Bernards R; Wang C
Genome Med; 2021 Oct; 13(1):166. PubMed ID: 34663432
[TBL] [Abstract][Full Text] [Related]
17. ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1.
Zhang J; Zhang J; Wei Y; Li Q; Wang Q
Cell Death Dis; 2019 Oct; 10(11):811. PubMed ID: 31649264
[TBL] [Abstract][Full Text] [Related]
18. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
[TBL] [Abstract][Full Text] [Related]
19. MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling.
Zhao J; Li L; Yang T
J Cell Physiol; 2020 Dec; 235(12):9718-9728. PubMed ID: 32401366
[TBL] [Abstract][Full Text] [Related]
20. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
Dang Y; Zhang L; Wang X
J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]